Yesterday's announced financings: May 30

Here’s your roundup of yesterday's announced equity financings, courtesy of PrivatePlacements.com: the only database that tracks every financing, every day.

1. NFI Group Inc. (TSX: NFI)

• Gross Proceeds: $108 million
• Sector: Electric buses
• Units issued: 13.13 million
• Type: Subscription receipts
• Price: $8.25
• Warrants: None
• Agents: BMO Capital Markets, others       
• Use of Proceeds: Outstanding the debts

Company breakdown:

• Company that develops electric buses
• Recently received an order for 346 buses
• Closed a previous recent financing with Coliseum was for US$150 million

2. Eldorado Gold Corp. (TSX: ELD)

• Gross Proceeds: $135 million
• Sector: Precious metals
• Units issued: 10.4 million
• Type: Common shares
• Price: $13.00
• Warrants: None
• Agents: BMO Capital Markets       
• Use of Proceeds: Growth initiatives

Company breakdown:

• Gold producer developing projects in Turkey, Canada, Greece, and Romania
• Announced a €‎680 million financing for its Skouries projects in northern Greece in December
• Has 12.03 million ounces of gold reserves

3. Psyched Wellness Ltd. (CSE: PSYC)

• Gross Proceeds: US$7.5 million
• Sector: Wellness
• Units issued: 100 million
• Type: Special units; Flow-through units
• Price: $0.07
• Warrants: Full; $0.10; Five years
• Agents: Non-brokered        
• Use of Proceeds: Working capital

Company breakdown:

• Researches and produces products using the amanita muscaria mushroom
• Recently rolled out amanita gummies

4. Fuelpositive Corp. (TSX-V: NHHH)

• Gross Proceeds: $7.5 million
• Sector: Clean tech
• Units issued: 115.38 million
• Type: Special units
• Price: $0.065
• Warrants: Full; $0.09; Three years
• Agents: Non-brokered        
• Use of Proceeds: Commercialization

Company breakdown:

• Clean tech company working to commercialize "green ammonia" which it argues could be more practical than green hydrogen
• Proceeds from the offering will be used toward demonstration systems for the commercialization of green ammonia

5. Alpha Cognition Inc. (CSE: ACOG)

• Gross Proceeds: US$6.5 million
  Sector: Biopharmaceuticals
  Units issued: 29.55 million
  Type: Special units
  Price: US$0.22
  Warrants: Half; US$0.31; Three years
  Agents: Non-brokered        
  Use of Proceeds: R&D

Company breakdown:

• Developing treatments for patients suffering neurodegenerative diseases like Alzheimer's
• Main focus is ALPHA-1062 for mild-to-moderate Alzheimer's, aiming to get an oral tablet approved by the FDA